476 related articles for article (PubMed ID: 26681753)
1. Carboxyl-Terminal Cleavage of Apolipoprotein A-I by Human Mast Cell Chymase Impairs Its Anti-Inflammatory Properties.
Nguyen SD; Maaninka K; Lappalainen J; Nurmi K; Metso J; Öörni K; Navab M; Fogelman AM; Jauhiainen M; Lee-Rueckert M; Kovanen PT
Arterioscler Thromb Vasc Biol; 2016 Feb; 36(2):274-84. PubMed ID: 26681753
[TBL] [Abstract][Full Text] [Related]
2. Chymase released from hypoxia-activated cardiac mast cells cleaves human apoA-I at Tyr
Kareinen I; Baumann M; Nguyen SD; Maaninka K; Anisimov A; Tozuka M; Jauhiainen M; Lee-Rueckert M; Kovanen PT
J Lipid Res; 2018 Jun; 59(6):945-957. PubMed ID: 29581158
[TBL] [Abstract][Full Text] [Related]
3. Identification of domains in apoA-I susceptible to proteolysis by mast cell chymase. Implications for HDL function.
Lee M; Uboldi P; Giudice D; Catapano AL; Kovanen PT
J Lipid Res; 2000 Jun; 41(6):975-84. PubMed ID: 10828090
[TBL] [Abstract][Full Text] [Related]
4. Mast cell chymase degrades apoE and apoA-II in apoA-I-knockout mouse plasma and reduces its ability to promote cellular cholesterol efflux.
Lee M; Calabresi L; Chiesa G; Franceschini G; Kovanen PT
Arterioscler Thromb Vasc Biol; 2002 Sep; 22(9):1475-81. PubMed ID: 12231569
[TBL] [Abstract][Full Text] [Related]
5. Detection of chymase-digested C-terminally truncated apolipoprotein A-I in normal human serum.
Usami Y; Matsuda K; Sugano M; Ishimine N; Kurihara Y; Sumida T; Yamauchi K; Tozuka M
J Immunol Methods; 2011 Jun; 369(1-2):51-8. PubMed ID: 21497162
[TBL] [Abstract][Full Text] [Related]
6. Human apolipoprotein A-I exerts a prophylactic effect on high-fat diet-induced atherosclerosis via inflammation inhibition in a rabbit model.
Li J; Wang W; Han L; Feng M; Lu H; Yang L; Hu X; Shi S; Jiang S; Wang Q; Ye L
Acta Biochim Biophys Sin (Shanghai); 2017 Feb; 49(2):149-158. PubMed ID: 28069582
[TBL] [Abstract][Full Text] [Related]
7. Human macrophage cathepsin B-mediated C-terminal cleavage of apolipoprotein A-I at Ser228 severely impairs antiatherogenic capacity.
Dinnes DL; White MY; Kockx M; Traini M; Hsieh V; Kim MJ; Hou L; Jessup W; Rye KA; Thaysen-Andersen M; Cordwell SJ; Kritharides L
FASEB J; 2016 Dec; 30(12):4239-4255. PubMed ID: 27630170
[TBL] [Abstract][Full Text] [Related]
8. The apolipoprotein A-I mimetic peptide ETC-642 exhibits anti-inflammatory properties that are comparable to high density lipoproteins.
Di Bartolo BA; Nicholls SJ; Bao S; Rye KA; Heather AK; Barter PJ; Bursill C
Atherosclerosis; 2011 Aug; 217(2):395-400. PubMed ID: 21571275
[TBL] [Abstract][Full Text] [Related]
9. Recombinant lectin-like domain of thrombomodulin suppresses vascular inflammation by reducing leukocyte recruitment via interacting with Lewis Y on endothelial cells.
Lin WL; Chang CF; Shi CS; Shi GY; Wu HL
Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2366-73. PubMed ID: 23950139
[TBL] [Abstract][Full Text] [Related]
10. Depletion of pre beta 1LpA1 and LpA4 particles by mast cell chymase reduces cholesterol efflux from macrophage foam cells induced by plasma.
Lee M; von Eckardstein A; Lindstedt L; Assmann G; Kovanen PT
Arterioscler Thromb Vasc Biol; 1999 Apr; 19(4):1066-74. PubMed ID: 10195937
[TBL] [Abstract][Full Text] [Related]
11. Mast cell chymase induces smooth muscle cell apoptosis by disrupting NF-kappaB-mediated survival signaling.
Leskinen MJ; Heikkilä HM; Speer MY; Hakala JK; Laine M; Kovanen PT; Lindstedt KA
Exp Cell Res; 2006 May; 312(8):1289-98. PubMed ID: 16460729
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein A-I mimetic 4F alters the function of human monocyte-derived macrophages.
Smythies LE; White CR; Maheshwari A; Palgunachari MN; Anantharamaiah GM; Chaddha M; Kurundkar AR; Datta G
Am J Physiol Cell Physiol; 2010 Jun; 298(6):C1538-48. PubMed ID: 20219948
[TBL] [Abstract][Full Text] [Related]
13. Neopterin Counters Vascular Inflammation and Atherosclerosis.
Shirai R; Sato K; Yamashita T; Yamaguchi M; Okano T; Watanabe-Kominato K; Watanabe R; Matsuyama TA; Ishibashi-Ueda H; Koba S; Kobayashi Y; Hirano T; Watanabe T
J Am Heart Assoc; 2018 Feb; 7(3):. PubMed ID: 29420219
[TBL] [Abstract][Full Text] [Related]
14. META060 attenuates TNF-α-activated inflammation, endothelial-monocyte interactions, and matrix metalloproteinase-9 expression, and inhibits NF-κB and AP-1 in THP-1 monocytes.
Desai A; Darland G; Bland JS; Tripp ML; Konda VR
Atherosclerosis; 2012 Jul; 223(1):130-6. PubMed ID: 22658256
[TBL] [Abstract][Full Text] [Related]
15. The 5A apolipoprotein A-I mimetic peptide displays antiinflammatory and antioxidant properties in vivo and in vitro.
Tabet F; Remaley AT; Segaliny AI; Millet J; Yan L; Nakhla S; Barter PJ; Rye KA; Lambert G
Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):246-52. PubMed ID: 19965776
[TBL] [Abstract][Full Text] [Related]
16. Nonenzymatic glycation impairs the antiinflammatory properties of apolipoprotein A-I.
Nobécourt E; Tabet F; Lambert G; Puranik R; Bao S; Yan L; Davies MJ; Brown BE; Jenkins AJ; Dusting GJ; Bonnet DJ; Curtiss LK; Barter PJ; Rye KA
Arterioscler Thromb Vasc Biol; 2010 Apr; 30(4):766-72. PubMed ID: 20110571
[TBL] [Abstract][Full Text] [Related]
17. Mediators released from LPS-challenged lungs induce inflammatory responses in liver vascular endothelial cells and neutrophilic leukocytes.
Markovic N; McCaig LA; Stephen J; Mizuguchi S; Veldhuizen RA; Lewis JF; Cepinskas G
Am J Physiol Gastrointest Liver Physiol; 2009 Dec; 297(6):G1066-76. PubMed ID: 19815624
[TBL] [Abstract][Full Text] [Related]
18. Mast cell activation in vivo impairs the macrophage reverse cholesterol transport pathway in the mouse.
Lee-Rueckert M; Silvennoinen R; Rotllan N; Judström I; Blanco-Vaca F; Metso J; Jauhiainen M; Kovanen PT; Escola-Gil JC
Arterioscler Thromb Vasc Biol; 2011 Mar; 31(3):520-7. PubMed ID: 21212401
[TBL] [Abstract][Full Text] [Related]
19. Mast cell chymase degrades the alarmins heat shock protein 70, biglycan, HMGB1, and interleukin-33 (IL-33) and limits danger-induced inflammation.
Roy A; Ganesh G; Sippola H; Bolin S; Sawesi O; Dagälv A; Schlenner SM; Feyerabend T; Rodewald HR; Kjellén L; Hellman L; Åbrink M
J Biol Chem; 2014 Jan; 289(1):237-50. PubMed ID: 24257755
[TBL] [Abstract][Full Text] [Related]
20. Identification of sites in apolipoprotein A-I susceptible to chymase and carboxypeptidase A digestion.
Usami Y; Kobayashi Y; Kameda T; Miyazaki A; Matsuda K; Sugano M; Kawasaki K; Kurihara Y; Kasama T; Tozuka M
Biosci Rep; 2012 Dec; 33(1):49-56. PubMed ID: 23072735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
